Indian Journal of Clinical and Experimental Ophthalmology

Print ISSN: 2395-1443

Online ISSN: 2395-1451

CODEN : IJCEKF

Indian Journal of Clinical and Experimental Ophthalmology (IJCEO) is open access, a peer-reviewed medical journal, published quarterly, online, and in print, by the Innovative Education and Scientific Research Foundation (IESRF) since 2015. To fulfil our aim of rapid dissemination of knowledge, we publish articles ‘Ahead of Print’ on acceptance. In addition, the journal allows free access (Open Access) to its content, which is likely to attract more readers and citations of articles published in IJCEO. Manuscripts must be prepared in more...

Article type

Review Article


Article page

9-18


Authors Details

Lalit Pawaskar*, Amit Sharma, Mayuresh Kiran


Article Metrics


View Article As

 


Downlaod Files

   






Article statistics

Viewed: 391

PDF Downloaded: 179


Dietary supplements and drugs available in India along with the mechanism of action and clinical trial data for the medical management of age related macular degeneration (AMD)


Review Article

Author Details : Lalit Pawaskar*, Amit Sharma, Mayuresh Kiran

Volume : 9, Issue : 1, Year : 2023

Article Page : 9-18

https://doi.org/10.18231/j.ijceo.2023.003



Suggest article by email

Get Permission

Abstract

Age related macular degeneration (AMD) is one of the leading cause of blindness among elderly population which diminishes the visual quality. The main objective behind this review is to give the brief information about the dietary supplements and drugs which are available in India along with the mechanism of action and clinical trial data for the management for AMD. Also, we have commented, wherever any additional clinical trial data or regulatory approvals would be needed for using the pharmaceutical or nutraceutical product in Indian patients. The dietary supplements reviewed in this article includes Lutein and Zeaxanthin which are also referred as macular pigments and have important role in absorption of blue light prior reaching to the retina and have antioxidant functions, Zinc which has structural role in antioxidant enzymes, Copper which is cofactor for several ocular-enzymes, Astaxanthin, Vitamin C, Vitamin E, Resveratrol and Glutathione which are antioxidants. We have also reviewed Brimonidine for the management of non-neovascular AMD. Brimonidine is an alpha 2-adrenergic agonist but along with that it has neuroprotective as well as cytoprotective activities because of which it can be used for the management of non-neovascular AMD. In this review we have discussed many clinical trials for different combinations of above-mentioned dietary supplements and out of which AREDS 2 clinical trial was conducted on comparatively larger number of patients and for longer study duration.
 

Keywords: Non-neovascular age related macular degeneration, Lutein, Zeaxanthin, Zinc, Copper, Astaxanthin, Vitamin C, Vitamin E, Resveratrol, Glutathione and brimonidine


How to cite : Pawaskar L, Sharma A, Kiran M, Dietary supplements and drugs available in India along with the mechanism of action and clinical trial data for the medical management of age related macular degeneration (AMD). Indian J Clin Exp Ophthalmol 2023;9(1):9-18

This is an Open Access (OA) journal, and articles are distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 License, which allows others to remix, tweak, and build upon the work non-commercially, as long as appropriate credit is given and the new creations are licensed under the identical terms.